These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34695509)

  • 1. Innovation in drug toxicology: Application of mass spectrometry imaging technology.
    Jiang H; Gao S; Hu G; He J; Jin H
    Toxicology; 2021 Dec; 464():153000. PubMed ID: 34695509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry Imaging and Its Application in Forensic Toxicology.
    Zhou LY; Wang X; Xiang P
    Fa Yi Xue Za Zhi; 2021 Jun; 37(3):402-401. PubMed ID: 34379912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative mass spectrometry imaging of drugs and metabolites.
    Lietz CB; Gemperline E; Li L
    Adv Drug Deliv Rev; 2013 Jul; 65(8):1074-85. PubMed ID: 23603211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging mass spectrometry in drug development and toxicology.
    Karlsson O; Hanrieder J
    Arch Toxicol; 2017 Jun; 91(6):2283-2294. PubMed ID: 27933369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial analysis of drug absorption, distribution, metabolism, and toxicology using mass spectrometry imaging.
    Spruill ML; Maletic-Savatic M; Martin H; Li F; Liu X
    Biochem Pharmacol; 2022 Jul; 201():115080. PubMed ID: 35561842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass Spectrometry Imaging: Applications in Drug Distribution Studies.
    Zhao YS; Li C
    Curr Drug Metab; 2015; 16(9):807-15. PubMed ID: 26264197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mass spectrometry imaging technology and its application in breast cancer research].
    Zhang M; Zhang Y; Wang H; Li N; Li B; Xiao H; Bian W; Cai Z
    Se Pu; 2021 Jun; 39(6):578-587. PubMed ID: 34227318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging.
    Chen B; Vavrek M; Cancilla MT
    J Mass Spectrom; 2024 May; 59(5):e5029. PubMed ID: 38656528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues.
    Porta Siegel T; Hamm G; Bunch J; Cappell J; Fletcher JS; Schwamborn K
    Mol Imaging Biol; 2018 Dec; 20(6):888-901. PubMed ID: 30167993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry imaging of pharmacological compounds in tissue sections.
    Goodwin RJ; Pitt AR
    Bioanalysis; 2010 Feb; 2(2):279-93. PubMed ID: 21083310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison.
    Lamont L; Hadavi D; Viehmann B; Flinders B; Heeren RMA; Vreeken RJ; Porta Siegel T
    Anal Bioanal Chem; 2021 Apr; 413(10):2779-2791. PubMed ID: 33770207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative mass spectrometry imaging of drugs and metabolites in tissue at therapeutic levels.
    Sun N; Walch A
    Histochem Cell Biol; 2013 Aug; 140(2):93-104. PubMed ID: 23881163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues.
    Drexler DM; Garrett TJ; Cantone JL; Diters RW; Mitroka JG; Prieto Conaway MC; Adams SP; Yost RA; Sanders M
    J Pharmacol Toxicol Methods; 2007; 55(3):279-88. PubMed ID: 17222568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry imaging for drug distribution studies.
    Prideaux B; Stoeckli M
    J Proteomics; 2012 Aug; 75(16):4999-5013. PubMed ID: 22842290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric imaging of the nervous system.
    Rubakhin SS; Hatcher NG; Monroe EB; Heien ML; Sweedler JV
    Curr Pharm Des; 2007; 13(32):3325-34. PubMed ID: 18045186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE SPACE DIMENSION AT THE MICRO LEVEL: MASS SPECTROMETRY IMAGING OF DRUGS IN TISSUES.
    Davoli E; Zucchetti M; Matteo C; Ubezio P; D'Incalci M; Morosi L
    Mass Spectrom Rev; 2021 May; 40(3):201-214. PubMed ID: 32501572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolite mapping by consecutive nanostructure and silver-assisted mass spectrometry imaging on tissue sections.
    Gustafsson OJR; Guinan TM; Rudd D; Kobus H; Benkendorff K; Voelcker NH
    Rapid Commun Mass Spectrom; 2017 Jun; 31(12):991-1000. PubMed ID: 28370605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug localizations in tissue by mass spectrometry imaging.
    Végvári Á
    Biomark Med; 2015; 9(9):869-76. PubMed ID: 26328625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging and spatially resolved quantification of drug distribution in tissues by mass spectrometry.
    Prideaux B; Lenaerts A; Dartois V
    Curr Opin Chem Biol; 2018 Jun; 44():93-100. PubMed ID: 29957376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mass spectrometry imaging technology and its application in medicinal plants research].
    Peng L; Chen HG; Zhou X
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1023-1033. PubMed ID: 32237441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.